Article Details

Berlin's Thiel-backed psychedelics startup Atai valued at $3.19bn at Nasdaq debut

Retrieved on: 2021-06-19 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Berlin's Thiel-backed psychedelics startup Atai valued at $3.19bn at Nasdaq debut. View article details on hiswai:

Excerpt

Shares' prices of Atai Life Sciences BV, a German psychedelics drugmaker backed by billionaire investor Peter Thiel, skyrocketed as much as 40 per ...

Article found on: www.financial-world.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up